Key result
A 10-lncRNA nomogram accurately distinguishes dilated cardiomyopathy with an AUC of ~1.0.
Why the study?
Precise molecular drivers of dilated cardiomyopathy, especially regarding abnormal immune responses, remain unclear.
Observational (n=460)
Answers are grounded in this paper and cite their sources.
Ten immune-related lncRNAs were identified as potential diagnostic biomarkers and subtyping tools for dilated cardiomyopathy.
Background: Various physiological mechanisms are linked to dilated cardiomyopathy (DCM) development, including oxidative stress, immune irregularities, inflammation, fibrosis, and genetic changes. However, precise molecular drivers of DCM, especially regarding abnormal immune responses, remain unclear. This study investigates immune-related long non-coding RNAs (lncRNAs) in DCM’s diagnostic and therapeutic potential. Methods: GSE141910, GSE135055, and GSE165303 datasets were acquired from the GEO database. LASSO, SVM-RFE, and random forest algorithms identified DCM-associated immune-related lncRNAs. Diagnostic capabilities were assessed by Nomogram and receiver operating characteristic (ROC) curves. Multivariate linear regression explored lncRNA correlations with ejection fraction. Single-sample gene set enrichment analysis (ssGSEA) gauged immune cell infiltration/functions. Functional enrichment analyses were performed using Gene set variation analysis (GSVA), gene ontology (GO), and the Kyoto Encyclopedia of Genes and Genomes (KEGG). Consensus clustering categorized DCM cases. Results: Ten immune-related lncRNAs emerged: C10orf71-AS1, FHAD1-AS1, SCIRT, FNDC1-AS1, MELTFAS1, LOC101928834, GDNF-AS1, DCXR-DT, C3orf36, and LOC107985323. These lncRNAs, tied to immunomodulation, showed promising DCM diagnostic accuracy. Adjusted for confounders, they independently correlated with ejection fraction. Using lncRNA expression, DCM patients were grouped into subtypes. Subtype C1 displayed a higher level of immune cell infiltration and immune checkpoint expression compared to subtype C2, emphasizing the variations in the immune microenvironment. Conclusion: This study identifies ten immune-related lncRNAs for further exploration in DCM diagnosis and subtyping. Based on expression patterns, we propose two potential DCM subtypes. Notably, findings are preliminary and hypothesis-generating, demanding validation and further investigation. This research provides insights into DCM diagnosis and classification.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2023) conducted an observational in Dilated cardiomyopathy (DCM) (n=460). 10 immune-related lncRNAs expression signature vs. Normal myocardial tissue was evaluated on Diagnostic accuracy (Area Under the Curve) for dilated cardiomyopathy using a 10-lncRNA nomogram model (AUC 0.998). A signature of 10 immune-related lncRNAs accurately distinguished dilated cardiomyopathy from normal myocardial tissue, with a combined nomogram model achieving a diagnostic AUC of 0.998 in an external validation dataset.
Synapse has enriched 10 related papers. Consider them for comparative context: